A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled Study of AG-120 in Previously-treated Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation
Phase: PHASE3
Conditions: Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma
Sponsor: Institut de Recherches Internationales Servier

 
Official Title: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-
Controlled Study of AG-120 in Previously Treated Subjects with 
Nonresectable or Metastatic Cholangiocarcinoma with an IDH1 
Mutation 
NCT Number: NCT02989857 
Document Date: Protocol Version 7: 23-June-2021